ArticleClinical ophthalmology (Auckland, N.Z.)2026
To Evaluate the Agreement and Repeatability of the Eyerobo VS Portable Autorefractor Cycloplegic Refraction in Children and Adolescents.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the agreement of the Eyerobo VS with the ARK-1 and subjective refraction (SR) and repeatability of the Eyerobo VS three measurements cycloplegic refraction in children and adolescents. Patients and Methods: This study included 158 participants (316 eyes) aged 10.33 ± 2.10. All participants underwent eye examinations, including the ARK-1, the Eyerobo VS, and SR. The refractive error-related parameters included Sphere, spherical equivalent (SE), J0, and J45. Bland-Altman analysis was used to assess the agreement between the Eyerobo VS and the ARK-1 and the agreement between the Eyerobo VS and SR. The intraclass correlation coefficient (ICC) was used to evaluate the repeatability of the Eyerobo VS three measurements. Results: The Eyerobo VS showed agreement with the ARK-1 within 0.5 D of 81.0% (Sphere), 79.4% (SE), 96.8% (J0), and 99.7% (J45). The Eyerobo VS showed agreement with SR within 0.5 D of 82.9% (Sphere), 79.4% (SE), 96.2% (J0), and 100.0% (J45). The ICC for the three measurements of the Eyerobo VS was 0.97 for Sphere and 0.95 for SE, respectively. Conclusion: The refractive measurement cycloplegic refraction of the Eyerobo VS showed high reliability and good agreement with the ARK-1 and SR on Sphere, SE, J0, and J45. The Eyerobo VS portable autorefractor could facilitate large-scale vision screening in schools and remote areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.